The presence of valine at residue 129 in human prion protein accelerates amyloid formation

FEBS Letters

Volumn 579, Issue 12, 2005, Pages 2589-2596

  Baskakov, Ilia ^a   Disterer, Petra ^b   Breydo, Leonid ^a   Shaw, Michael ^b   Gill, Andrew ^c   James, William ^b   Tahiri Alaoui, Abdessamad ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Amyloid; Codon 129; Folding; Polymorphism; Prions

Indexed keywords

AMYLOID; PRION PROTEIN; VALINE;

ALLELE; ARTICLE; CODON; DNA POLYMORPHISM; EXAMINATION; GENETIC LINKAGE; INCUBATION TIME; KINETICS; OLIGOMERIZATION; ONSET AGE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 18144416596     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.03.075     Document Type: Article

References (37)

1. M.S. Palmer, A.J. Dryden, J.T. Hughes, and J. Collinge Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease Nature 352 1991 340 342
2. P. Brown Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine Neurology 44 1994 291 293
3. J. Collinge, M.S. Palmer, and A.J. Dryden Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease Lancet 337 1991 1441 1442
4. H.E. Baker, M. Poulter, T.J. Crow, C.D. Frith, R. Lofthouse, and R.M. Ridley Aminoacid polymorphism in human prion protein and age at death in inherited prion disease Lancet 337 1991 1286
5. L. Cervenakova, L.G. Goldfarb, R. Garruto, H.S. Lee, D.C. Gajdusek, and P. Brown Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease Proc. Natl. Acad. Sci. USA 95 1998 13239 13241
6. P. Parchi Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects Ann. Neurol. 46 1999 224 233
7. I.V. Baskakov, G. Legname, S.B. Prusiner, and F.E. Cohen Folding of prion protein to its native alpha-helical conformation is under kinetic control J. Biol. Chem. 276 2001 19687 19690
8. I.V. Baskakov, G. Legname, M.A. Baldwin, S.B. Prusiner, and F.E. Cohen Pathway complexity of prion protein assembly into amyloid J. Biol. Chem. 277 2002 21140 21148
9. A. Tahiri-Alaoui, A.C. Gill, P. Disterer, and W. James Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to CJD J. Biol. Chem. 279 2004 31390 31397
10. A. Tahiri-Alaoui, and W. James Rapid formation of amyloid from {alpha}-monomeric recombinant human PrP in vitro Protein Sci. 14 2005 942 947
11. S. Liemann, and R. Glockshuber Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein Biochemistry 38 1999 3258 3267
12. R. Riek, G. Wider, M. Billeter, S. Hornemann, R. Glockshuber, and K. Wuthrich Prion protein NMR structure and familial human spongiform encephalopathies Proc. Natl. Acad. Sci. USA 95 1998 11667 11672
13. L.L.P. Hosszu The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC J. Biol. Chem. 279 2004 28515 28521
14. I.V. Baskakov, G. Legname, Z. Gryczynski, and S.B. Prusiner The peculiar nature of unfolding of the human prion protein Protein Sci. 13 2004 586 595
15. G. Legname, I.V. Baskakov, H.O. Nguyen, D. Riesner, F.E. Cohen, S.J. DeArmond, and S.B. Prusiner Synthetic mammalian prions Science 305 2004 673 676
16. S.B. Prusiner Novel proteinaceous infectious particles cause scrapie Science 216 1982 136 144
17. J. Wall, M. Schell, C. Murphy, R. Hrncic, F.J. Stevens, and A. Solomon Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity Biochemistry 38 1999 14101 14108
18. A. Tahiri-Alaoui, M. Bouchard, J. Zurdo, and W. James Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptides Protein Sci. 12 2003 600 608
19. O.V. Bocharova, L. Breydo, A.S. Parfenov, V.V. Salnikov, and I.V. Baskakov In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc) J. Mol. Biol. 346 2005 645 659
20. Bocharova, O.V., Breydo, L., Salnikov, V.V., Gill, A. and Baskakov, I.V. (2005) Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob disease. Protein Sci., in press
21. G.D. Fasman Protein conformational prediction Trends Biochem. Sci. 14 1989 295 299
22. C.A. Kim, and J.M. Berg Thermodynamic beta-sheet propensities measured using a zinc-finger host peptide Nature 362 1993 267 270
23. S. Santini, J.B. Claude, S. Audic, and P. Derreumaux Impact of the tail and mutations G131V and M129V on prion protein flexibility Proteins 51 2003 258 265
24. R. Riek, S. Hornemann, G. Wider, M. Billeter, R. Glockshuber, and K. Wuthrich NMR structure of the mouse prion protein domain PrP (121-321) Nature 382 1996 180 182
25. N. Sanghera, and T.J. Pinheiro Binding of prion protein to lipid membranes and implications for prion conversion J. Mol. Biol. 315 2002 1241 1256
26. P.K. Nandi, E. Leclerc, and D. Marc Unusual property of prion protein unfolding in neutral salt solution Biochemistry 41 2002 11017 11024
27. N.R. Deleault, R.W. Lucassen, and S. Supattapone RNA molecules stimulate prion protein conversion Nature 425 2003 717 720
28. P.K. Nandi, E. Leclerc, J.C. Nicole, and M. Takahashi DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid J. Mol. Biol. 322 2002 153 161
29. S.B. Prusiner Molecular biology of prion diseases Science 252 1991 1515 1522
30. I.V. Baskakov Autocatalytic conversion of recombinant prion proteins displays a species barrier J. Biol. Chem. 279 2004 7671 7677
31. O. Windl Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene Hum. Genet. 98 1996 259 264
32. J.L. Laplanche, N. Delasnerie-Laupretre, J.P. Brandel, J. Chatelain, P. Beaudry, A. Alperovitch, and J.M. Launay Molecular genetics of prion diseases in France. French research group on epidemiology of human spongiform encephalopathies Neurology 44 1994 2347 2351
33. W.J. Schulz-Schaeffer, A. Giese, O. Windl, and H.A. Kretzschmar Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease Clin. Neuropathol. 15 1996 353 357
34. J.J. Hauw Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene Neurology 54 2000 1641 1646
35. A. Alperovitch Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease Lancet 353 1999 1673 1674
36. A.F. Hill, M. Desbruslais, S. Joiner, K.C. Sidle, I. Gowland, J. Collinge, L.J. Doey, and P. Lantos The same prion strain causes vCJD and BSE Nature 389 1997 448 450 526
37. E.A. Asante BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein EMBO J. 21 2002 6358 6366